Abstract
Vitamin D deficiency has become a globally acknowledged problem whose impact on societies has proven to surpass all medical expectations. Vitamin D is no longer peerlessly associated with bone diseases. In fact, collaborations of clinicians and researchers have yielded the undeniable truth, that is, the affiliation of this unconventional vitamin with diseases that are currently grasping the media’s attention like autoimmune diseases and cancers. Having established the importance of this phenomenon, assuming complete understanding of the association of vitamin D with one of the leading causes of death in the world, cardiovascular disease, is only mildly precise. Observational studies tend to highlight the association of low vitamin D levels with various forms of cardiovascular disease as well as with the risk factors associated, whereas interventional studies have been conflicting. Nonetheless, in vitro studies have identified the presence of nuclear vitamin D receptors in the cardiovascular system in cells such as cardiomyocytes and endothelial cells, thereby warranting cardiovascular actions. Moreover, recent studies have demonstrated the ability of vitamin D to beneficially modulate effectors of the cardiovascular system such as the renin-angiotensin-aldosterone system and the nitric oxide system. While there appears to be abundance in the number of publications on the epidemiological and mechanistic association of the vitamin with the disease, studies aiming to investigate the genetic component of the relationship are sparse. Recent genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in genes encoding proteins involved in the vitamin D pathway, whether synthesis, metabolism, or elimination, that are associated with circulating levels of 25-hydroxyvitamin D [25(OH)D], the biomarker of vitamin D status, and thus it is conceptualized that such SNPs may act as novel genetic markers for cardiovascular disease since the disease has been associated with low levels of 25(OH)D. Several studies have investigated this hypothesis, yielding both positive and negative associations, highlighting the need for further investigations into the proposed triangular relationships between the SNPs, 25(OH)D levels, and the disease, which would spawn sound evidence prompting or discouraging professionals to extrapolate the findings to clinical genetic testing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 1,25(OH)2D:
-
1,25-Dihydroxyvitamin D/calcitriol
- 25(OH)D:
-
25-Hydroxyvitamin D
- 7-DHC:
-
7-Dehydrocholesterol
- ADMA:
-
Asymmetric dimethylarginine
- CVD:
-
Cardiovascular disease
- CYP:
-
Cytochrome P450
- eNOS:
-
Endothelial nitric oxide synthase
- GWAS:
-
Genome-wide association study
- MI:
-
Myocardial infarction
- NO:
-
Nitric oxide
- RAAS:
-
Renin-angiotensin-aldosterone system
- RCT:
-
Randomized controlled trial
- ROS:
-
Reactive oxygen species
- SNP:
-
Single nucleotide polymorphism
- UV-B:
-
Ultraviolet-B
- VDR:
-
Vitamin D receptor
- VDRG:
-
Vitamin D receptor gene
References
Abu El Maaty MA, Gad MZ. Vitamin d deficiency and cardiovascular disease: potential mechanisms and novel perspectives. J Nutr Sci Vitaminol (Tokyo). 2013;59:479–88.
Abu El Maaty MA, Hassanein SI, Hanafi RS, et al. Insights on vitamin D’s role in cardiovascular disease: investigating the association of 25-hydroxyvitamin D with the dimethylated arginines. J Nutr Sci Vitaminol (Tokyo). 2013;59:172–7.
Abu El Maaty MA, Hassanein SI, Sleem HM, et al. Effect of polymorphisms in the NADSYN1/DHCR7 locus (rs12785878 and rs1790349) on plasma 25-hydroxyvitamin D levels and coronary artery disease incidence. J Nutrigenet Nutrigenomics. 2014;6:327–35.
Abu El Maaty MA, Hassanein SI, Sleem HM, et al. Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence. J Recept Signal Transduct Res. 2015;35(5):391.
Ahn J, Yu K, Stolzenberg-Solomon R, et al. Genome-wide association study of circulating vitamin D levels. Hum Mol Genet. 2010;19:2739–45.
Andrukhova O, Slavic S, Zeitz U, et al. Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice. Mol Endocrinol. 2014;28:53–64.
Batai K, Murphy AB, Shah E, et al. Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum Genet. 2014;133:1395–405.
Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726–76.
Chen S, Law CS, Grigsby CL, et al. Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy. Circulation. 2011;124:1838–47.
Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A. 2004;101:7711–5.
Chun RF, Peercy BE, Orwoll ES, et al. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014;144(Pt A):132–7.
Daiger SP, Schanfield MS, Cavalli-Sforza LL. Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci U S A. 1975;72:2076–80.
Dong J, Wong SL, Lau CW, et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J. 2012;33:2980–90.
Dorjgochoo T, Delahanty R, Lu W, et al. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Cancer Epidemiol Biomarkers Prev. 2011;20:2313–6.
Dorjgochoo T, Shi J, Gao YT, et al. Genetic variants in vitamin D metabolism-related genes and body mass index: analysis of genome-wide scan data of approximately 7000 Chinese women. Int J Obes (Lond). 2012;36:1252–5.
Feldman D, Krishnan AV, Swami S, et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14:342–57.
Ferrarezi DA, Bellili-Munoz N, Dubois-Laforgue D, et al. Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: the DIABHYCAR prospective study. Diabetes Metab. 2013;39:263–70.
Giangreco AA, Nonn L. The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites. J Steroid Biochem Mol Biol. 2013;136:86–93.
Hassanein SI, Abu El Maaty MA, Sleem HM, et al. Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin d levels, and coronary artery disease incidence. Biomarkers. 2014;19:488–92.
Haussler MR, Jurutka PW, Mizwicki M, et al. Vitamin D receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab. 2011;25:543–59.
Hirschfeld J. Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins. Acta Pathol Microbiol Scand. 1959;47:160–8.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
Hossein-Nezhad A, Holick MF. Vitamin d for health: a global perspective. Mayo Clin Proc. 2013;88:720–55.
Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8:e58725.
Hossein-Nezhad A, Eshaghi SM, Maghbooli Z, et al. The role of vitamin D deficiency and vitamin d receptor genotypes on the degree of collateralization in patients with suspected coronary artery disease. Biomed Res Int. 2014;2014:304250.
Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–54.
Jacobs ET, Van Pelt C, Forster RE, et al. CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res. 2013;73:2563–73.
Jones G, Prosser DE, Kaufmann M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2012;523:9–18.
Jorde R, Schirmer H, Wilsgaard T, et al. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromso Study. PLoS One. 2012;7:e37295.
Kuan V, Martineau AR, Griffiths CJ, et al. DHCR7 mutations linked to higher vitamin D status allowed early human migration to northern latitudes. BMC Evol Biol. 2013;13:144.
Kuhn T, Kaaks R, Teucher B, et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study. PLoS One. 2013;8:e69080.
Laczmanski L, Milewicz A, Lwow F, et al. Vitamin D receptor gene polymorphism and cardiovascular risk variables in elderly Polish subjects. Gynecol Endocrinol. 2013;29:268–72.
Li YC. Molecular mechanism of vitamin D in the cardiovascular system. J Investig Med. 2011;59:868–71.
Maruyama R, Aoki F, Toyota M, et al. Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res. 2006;66:4574–83.
McAlindon TE, Felson DT, Zhang Y, et al. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med. 1996;125:353–9.
Merke J, Milde P, Lewicka S, et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989;83:1903–15.
Molinari C, Uberti F, Grossini E, et al. 1alpha,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells. Cell Physiol Biochem. 2011;27:661–8.
Mondul AM, Shui IM, Yu K, et al. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer – results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2013;22:688–96.
Mondul AM, Shui IM, YuK, et al. Vitamin D-associated genetic variation and risk of breast cancer in the Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2015;24(3):627–30.
Muscogiuri G, Sorice GP, Ajjan R, et al. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012;22:81–7.
Ngo DT, Sverdlov AL, McNeil JJ, et al. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med. 2010;123:335–41.
Ni W, Watts SW, Ng M, et al. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 2014;64:1290–8.
Oh JJ, Byun SS, Lee SE, et al. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population. Gene. 2014;533:86–93.
Ortlepp JR, von Korff A, Hanrath P, et al. Vitamin D receptor gene polymorphism BsmI is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest. 2003;33:106–9.
Ortlepp JR, Krantz C, Kimmel M, et al. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years. Int J Cardiol. 2005;105:90–5.
Pan XM, Li DR, Yang L, et al. No association between vitamin D receptor polymorphisms and coronary artery disease in a Chinese population. DNA Cell Biol. 2009;28:521–5.
Pilz S, Gaksch M, O’Hartaigh B, et al. The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013? Arch Toxicol. 2013;87:2083–103.
Prabhakar P, Majumdar V, Kulkarni GB, et al. Genetic variants of vitamin D receptor and susceptibility to ischemic stroke. Biochem Biophys Res Commun. 2015;456:631–6.
Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010;20:1352–60.
Reimers LL, Crew KD, Bradshaw PT, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015;26(2):187–203.
Santoro D, Gagliostro G, Alibrandi A, et al. Vitamin D receptor gene polymorphism and left ventricular hypertrophy in chronic kidney disease. Nutrients. 2014;6:1029–37.
Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981;10:337–41.
Scragg R. The Vitamin D Assessment (ViDA) study: https://www.fmhs.auckland.ac.nz/en/soph/about/our-departments/epidemiology-and-biostatistics/research/vida-study.html. 2011. Retrieved 5 Jan 2015.
Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol. 1990;19:559–63.
Shanker J, Maitra A, Arvind P, et al. Role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron Artery Dis. 2011;22:324–32.
Shen H, Bielak LF, Ferguson JF, et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2010;30:2648–54.
Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012;104:690–9.
Signorello LB, Shi J, Cai Q, et al. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS One. 2011;6:e28623.
Speeckaert MM, Speeckaert R, van Geel N, et al. Vitamin D binding protein: a multifunctional protein of clinical importance. Adv Clin Chem. 2014;63:1–57.
Strawbridge RJ, Deleskog A, McLeod O, et al. A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia. 2014;57:1159–72.
Talmor-Barkan Y, Bernheim J, Green J, et al. Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment. J Steroid Biochem Mol Biol. 2011;124:19–24.
Trummer O, Pilz S, Hoffmann MM, et al. Vitamin D and mortality: a Mendelian randomization study. Clin Chem. 2013;59:793–7.
Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143–56.
Vaidya A, Sun B, Forman JP, et al. The Fok1 vitamin D receptor gene polymorphism is associated with plasma renin activity in Caucasians. Clin Endocrinol (Oxf). 2011;74:783–90.
Valcheva P, Cardus A, Panizo S, et al. Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals. Atherosclerosis. 2014;235:247–55.
Velayoudom-Cephise FL, Larifla L, Donnet JP, et al. Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 2011;37:540–5.
Vimaleswaran KS, Cavadino A, Berry DJ, et al. Genetic association analysis of vitamin D pathway with obesity traits. Int J Obes (Lond). 2013;37:1399–406.
Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376:180–8.
Wang L, Chu A, Buring JE, et al. Common genetic variations in the vitamin D pathway in relation to blood pressure. Am J Hypertens. 2014;27:1387–95.
Wilke RA, Simpson RU, Mukesh BN, et al. Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics. 2009;10:1789–97.
Ye Z, Sharp SJ, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2015;3:35–42.
Yin L, Grandi N, Raum E, et al. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009;30:113–25.
Zhang Y, Wang X, Liu Y, et al. The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly. 2012;142:w13636.
Zhu JG, Ochalek JT, Kaufmann M, et al. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci U S A. 2013;110:15650–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Abu el Maaty, M.A., Hassanein, S.I., Gad, M.Z. (2016). Polymorphisms in the Vitamin D Pathway in Relation to 25-Hydroxyvitamin D Status and Cardiovascular Disease Incidence: Application to Biomarkers. In: Patel, V., Preedy, V. (eds) Biomarkers in Cardiovascular Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7678-4_23
Download citation
DOI: https://doi.org/10.1007/978-94-007-7678-4_23
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7677-7
Online ISBN: 978-94-007-7678-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences